Literature DB >> 9552323

Pharmaceutical granulation and tablet formulation using neural networks.

J G Kesavan1, G E Peck.   

Abstract

Current-day pharmaceutical formulation may be trial and error in nature due to the absence of a clear relationship between the formulation characteristics (output variables) and the material and process variables (input variables). Neural networks are networks of adaptable nodes, which through a process of learning from task examples, store experiential knowledge and make it available for prediction. Prediction of a model granulation and tablet system characteristics from the knowledge of material and process variables utilizing neural networks is the basis of this presentation. The formulation design contained the following variables: granulation equipment, diluent, method of binder addition, and the binder concentration. The material, process, granulation evaluation, and tablet evaluation data of the formulations were used as the data set for training and testing of the neural network models. A comparison of the neural network prediction performance with that of regression models was also done. Both the granulation model and the tablet model converged fairly rapidly in the training step. In the testing step, the predictions for all granulation model variables (geometric mean particle size, flow value, bulk density, and tap density) were satisfactory. In the tablet model, the predictions for disintegration and thickness were also satisfactory. The predictions for hardness and friability were less than satisfactory. Two situations where the neural network may not perform adequately are discussed. The neural network prediction is better or comparable for all the predicted variables in this study compared to regression methods. The results clearly show the applicability of neural networks to formulation modeling.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9552323     DOI: 10.3109/10837459609031434

Source DB:  PubMed          Journal:  Pharm Dev Technol        ISSN: 1083-7450            Impact factor:   3.133


  8 in total

1.  The use of artificial neural networks for the selection of the most appropriate formulation and processing variables in order to predict the in vitro dissolution of sustained release minitablets.

Authors:  Michael M Leane; Iain Cumming; Owen I Corrigan
Journal:  AAPS PharmSciTech       Date:  2003       Impact factor: 3.246

2.  Artificial neural networks in the modeling and optimization of aspirin extended release tablets with Eudragit L 100 as matrix substance.

Authors:  Svetlana Ibrić; Milica Jovanović; Zorica Djurić; Jelena Parojcić; Slobodan D Petrović; Ljiljana Solomun; Biljana Stupar
Journal:  AAPS PharmSciTech       Date:  2003       Impact factor: 3.246

3.  Generalization of a prototype intelligent hybrid system for hard gelatin capsule formulation development.

Authors:  Wendy I Wilson; Yun Peng; Larry L Augsburger
Journal:  AAPS PharmSciTech       Date:  2005-10-22       Impact factor: 3.246

4.  Modeling the pharmacokinetics and pharmacodynamics of a unique oral hypoglycemic agent using neural networks.

Authors:  Sam H Haidar; Steven B Johnson; Michael J Fossler; Ajaz S Hussain
Journal:  Pharm Res       Date:  2002-01       Impact factor: 4.200

Review 5.  Application of Artificial Neural Networks in the Process Analytical Technology of Pharmaceutical Manufacturing-a Review.

Authors:  Brigitta Nagy; Dorián László Galata; Attila Farkas; Zsombor Kristóf Nagy
Journal:  AAPS J       Date:  2022-06-14       Impact factor: 3.603

6.  Quetiapine Fumarate Extended-release Tablet Formulation Design Using Artificial Neural Networks.

Authors:  Esher Özçelik; Burcu Mesut; Buket Aksu; Yıldız Özsoy
Journal:  Turk J Pharm Sci       Date:  2017-11-20

7.  A Novel Artificial Intelligence System in Formulation Dissolution Prediction.

Authors:  Haoyu Wang; Chiew Foong Kwong; Qianyu Liu; Zhixin Liu; Zhiyuan Chen
Journal:  Comput Intell Neurosci       Date:  2022-08-08

8.  Application of Machine-Learning Algorithms for Better Understanding of Tableting Properties of Lactose Co-Processed with Lipid Excipients.

Authors:  Jelena Djuris; Slobodanka Cirin-Varadjan; Ivana Aleksic; Mihal Djuris; Sandra Cvijic; Svetlana Ibric
Journal:  Pharmaceutics       Date:  2021-05-05       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.